- (1) University of Cambridge, grid.5335.0
- (2) Aix-Marseille University, grid.5399.6
- (3) University of Chicago Medical Center, grid.412578.d
- (4) Mayo Clinic, grid.66875.3a
- (5) QIMR Berghofer Medical Research Institute, grid.1049.c
- (6) Rigshospitalet, grid.475435.4, Capital Region
- (7) Nottingham University Hospitals NHS Trust, grid.240404.6
Description of affected and unaffected carriers selected for BRCA2 GWAS Stage 1 and 2.